Surgery Partners Stock Surges on Analyst Confidence

Surgery Partners (SGRY) experienced a morning surge, with shares jumping 2.7% after Cantor Fitzgerald reiterated its 'Overweight' rating and $18.00 price target. The firm's analyst noted minor negative trends in recent ambulatory surgery center and outpatient nursing data.

Despite these slight headwinds, the overall outlook for Surgery Partners remains positive. Analysts anticipate the company will achieve profitability this year, with projected growth in net income. The stock was trading at $17.15, marking a 3.3% increase from its prior closing price.

Historically, Surgery Partners' stock has shown volatility, with notable price swings. A significant drop of 23.8% occurred eight months ago following third-quarter results that missed profit expectations and led to a lowered full-year financial forecast. The company also revised its full-year revenue and adjusted EBITDA guidance downward at that time.

Year-to-date, Surgery Partners is up 12.4%. However, at $17.15 per share, it remains 28.1% below its 52-week high of $23.84 reached in August 2025. A longer-term perspective reveals a substantial loss for investors who bought shares five years ago.